[1]
Ramsay, S., Naud, Élizabeth, Simonyan, D., Moore, K. and Bolduc, S. 2020. A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study. Canadian Urological Association Journal. 14, 6 (Jan. 2020), 192–8. DOI:https://doi.org/10.5489/cuaj.6247.